Amarantus Outlines LymPro Alzheimer's Diagnostic Development Strategy

Published April 21, 2013

Amarantus Outlines LymPro Alzheimer's Diagnostic Development Strategy
Filed under: dual diagnosis assessment

"The LymPro assay represents a blood-based peripheral means to assess the integrity of the regulatory function of the cellular machinery within the Central Nervous System," said Amarantus corporate advisor Adam J. Simon, Ph.D. "Although we all … We …
{Source}

Lundbeck Releases Positive Data for Selincro
Filed under: dual diagnosis assessment

Selincro is thought to reduce the reinforcing effects of alcohol, and thereby reduces the urge to drink alcohol.7,8 Selincro is a unique dual-acting opioid system modulator9,10 and works on the brain's motivational system, which is dysregulated in …
{Source}